Improvements in Health-related Quality of Life and Symptoms in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Final Results From the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine
- 11 September 2021
- journal article
- research article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 22 (2), 121-128
- https://doi.org/10.1016/j.clml.2021.09.008
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemiaSupportive Care in Cancer, 2013
- Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicityBlood, 2010
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st centuryBlood, 2008
- Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemiaLeukemia & Lymphoma, 2008
- Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patientsBritish Journal of Haematology, 2007
- Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological researchEuropean Journal of Cancer, 2006
- Quality of life in chronic lymphocytic leukemia: A neglected issueLeukemia & Lymphoma, 2005
- Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yrEuropean Journal of Haematology, 2004
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993